<!DOCTYPE html> <html lang="en" class=""></html><html> <head> <meta name="google-site-verification" content=""> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title>Nathan Constantine-Cooke</title> <meta name="author" content="Nathan Constantine-Cooke"> <meta name="description" content="Postdoctoral research associate characterising heterogeneity in IBD using longitudinal biomarker profiles. "> <meta name="keywords" content="IBD Precision-medicine Research"> <meta property="og:site_name" content="Nathan Constantine-Cooke"> <meta property="og:type" content="website"> <meta property="og:title" content="Nathan Constantine-Cooke | About"> <meta property="og:url" content="https://www.constantine-cooke.com/"> <meta property="og:description" content="Postdoctoral research associate characterising heterogeneity in IBD using longitudinal biomarker profiles. "> <meta property="og:image" content="favicon.png"> <meta property="og:locale" content="en"> <meta name="twitter:card" content="summary"> <meta name="twitter:title" content="About"> <meta name="twitter:description" content="Postdoctoral research associate characterising heterogeneity in IBD using longitudinal biomarker profiles. "> <meta name="twitter:image" content="favicon.png"> <meta name="twitter:site" content="@IBDNathan"> <meta name="twitter:creator" content="@IBDNathan"> <script defer type="application/ld+json">
      {
        "author":
        {
          "@type": "Person",
          "name": "Nathan  Constantine-Cooke"
        },
        "url": "https://www.constantine-cooke.com/",
        "@type": "WebSite",
        "description": "Postdoctoral research associate characterising heterogeneity in IBD using longitudinal biomarker profiles. 
",
        "headline": "About",
        "sameAs": ["https://orcid.org/0000-0002-4437-8713", "https://scholar.google.com/citations?user=2emHWR0AAAAJ", "https://www.researchgate.net/profile/Nathan-Constantine-Cooke", "https://github.com/nathansam", "https://www.linkedin.com/in/nathan-constantine-cooke", "https://twitter.com/IBDNathan", "https://www.ed.ac.uk/profile/constantine-cooke"],
        "name": "Nathan  Constantine-Cooke",
        "@context": "https://schema.org"
      }
    </script> <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png"> <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png"> <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png"> <link rel="manifest" href="/site.webmanifest"> <link rel="mask-icon" href="/safari-pinned-tab.svg" color="#5bbad5"> <meta name="viewport" content="width=device-width, initial-scale=1"> <link href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.1/dist/css/bootstrap.min.css" rel="stylesheet" integrity="sha256-DF7Zhf293AJxJNTmh5zhoYYIMs2oXitRfBjY+9L//AY=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5.15.4/css/all.min.css" integrity="sha256-mUZM63G8m73Mcidfrv5E+Y61y7a12O5mW4ezU3bxqW4=" crossorigin="anonymous"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha256-i1+4qU2G2860dGGIOJscdC30s9beBXjFfzjWLjBRsBg=" crossorigin="anonymous"> <link rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons"> <link rel="shortcut icon" type="image/png" href="favicon.png"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jwarby/jekyll-pygments-themes@master/github.css" media="" id="highlight_theme_light"> <link rel="stylesheet" href="/assets/css/main.css"> <link rel="canonical" href="https://www.constantine-cooke.com/"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/jwarby/jekyll-pygments-themes@master/native.css" media="none" id="highlight_theme_dark"> <script src="/assets/js/theme.js"></script> <script src="/assets/js/dark_mode.js"></script> </head> <body class="fixed-top-nav "> <div class="font-sans"> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="https://www.constantine-cooke.com/">Nathan <span class="font-weight-bold">Constantine-Cooke</span></a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item active"> <a class="nav-link" href="/">About</a> </li> <li class="nav-item "> <a class="nav-link" href="/blog/">Blog</a> </li> <li class="nav-item "> <a class="nav-link" href="/projects/">Projects</a> </li> <li class="nav-item "> <a class="nav-link" href="/repositories/">Repositories</a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">Publications</a> </li> <li class="nav-item "> <a class="nav-link" href="/teaching/">Teaching</a> </li> <li class="nav-item "> <a class="nav-link" href="/contact/">Contact</a> </li> <li class="nav-item "> <a class="nav-link" href="/cv/">CV</a> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="fas fa-moon"></i> <i class="fas fa-sun"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5"> <div class="post"> <h1 class="post-title text-3xl"> Nathan <span class="font-weight-bold">Constantine-Cooke</span> </h1> <p class="desc text-xl"><b>Affiliations:</b> Centre for Genomic and Experimental Medicine and MRC Human Genetics Unit</p> <br> <br> <article> <div class="md:flex gap-4"> <div class="flex-auto"> <p>I am a Postdoctoral Research Associate in Health Data Science at the <a href="https://www.ed.ac.uk/" rel="external nofollow noopener" target="_blank">University of Edinburgh</a> interested in modelling longitudinal biomarker trajectories and disease outcomes for inflammatory bowel disease. I am in the <a href="https://charlielees.com" rel="external nofollow noopener" target="_blank">Lees group</a> (<a href="https://www.ed.ac.uk/centre-genomic-medicine" rel="external nofollow noopener" target="_blank">Centre for Genomic and Experimental Medicine</a>) and in the <a href="https://vallejosgroup.github.io" rel="external nofollow noopener" target="_blank">Vallejos group</a> (<a href="https://www.ed.ac.uk/mrc-human-genetics-unit" rel="external nofollow noopener" target="_blank">MRC Human Genetics Unit</a>).</p> <p>My research interests include longitudinal modelling, survival analysis, electronic health records, and machine learning.</p> <p>I am also an R package developer. My packages can be found on <a href="https://www.github.com/nathansam" rel="external nofollow noopener" target="_blank">GitHub</a>.</p> <p>In my personal life, I enjoy swimming, the gym, playing bass guitar, and all things technology.</p> </div> <div class="rounded-xl justify-self-center flex-auto"> <picture> <source srcset="https://www.constantine-cooke.com/assets/img/prof_pic-800.webp" type="image/webp"> <source srcset="https://www.constantine-cooke.com/assets/img/prof_pic.jpg" type="image/jpeg"> <img src="https://www.constantine-cooke.com/assets/img/c.-vallejos-group-800.webp" alt="Avatar" class="w-60 rounded-3xl mx-auto"> </source></source></picture> </div> </div> <br> <div class="news"> <h2 class="text-2xl">News</h2> <div class="table-responsive"> <table class="table table-sm table-borderless"> <tr> <th scope="row">Jan 31, 2024</th> <td> <a class="news-title" href="/news/announcement_6/">I passed my viva!</a> </td> </tr> <tr> <th scope="row">Apr 6, 2023</th> <td> <em>Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease</em> is now available at <a href="https://doi.org/10.1016/j.cgh.2023.03.026" rel="external nofollow noopener" target="_blank">Clinical Gastroenterology and Hepatology</a>! </td> </tr> <tr> <th scope="row">Aug 17, 2022</th> <td> <em>Latent Crohn’s Disease Subgroups are Identified by Longitudinal Faecal Calprotectin Profiles</em> is available on <a href="https://www.medrxiv.org/content/10.1101/2022.08.16.22278320v1" rel="external nofollow noopener" target="_blank">medRxiv</a>! </td> </tr> <tr> <th scope="row">Mar 23, 2022</th> <td> <code class="language-plaintext highlighter-rouge">gameR</code> has been released on <a href="https://CRAN.R-project.org/package=gameR" rel="external nofollow noopener" target="_blank">CRAN</a>! </td> </tr> <tr> <th scope="row">Feb 19, 2022</th> <td> This website has gone live! </td> </tr> </table> </div> </div> <div class="publications"> <h2 class="text-2xl font-extralight">Selected publications</h2> <ol class="bibliography"> <li> <div class="row"> <div class="col-sm-2 abbr"><abbr class="badge">JCC</abbr></div> <div id="Gros_2024" class="col-sm-8"> <div class="title">Tofacitinib versus vedolizumab among bio-naïve patients with ulcerative colitis: A real-world propensity-weighted comparison</div> <div class="author"> <em>Nathan Constantine-Cooke</em>, Beatriz Gros, Jake Kennedy, Alexander T Elford, Claire O’Hare, Colin Noble, Gareth-Rhys Jones, Ian D Arnott, <a href="https://charlielees.com" rel="external nofollow noopener" target="_blank">Charlie W Lees</a>, and Nikolas Plevris </div> <div class="periodical"> <em>Journal of Crohn’s and Colitis</em> Dec 2024 </div> <div class="links"> <a class="bibtex btn btn-sm z-depth-0" role="button">Bib</a> <a href="http://dx.doi.org/10.1093/ecco-jcc/jjae188" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">URL</a> </div> <div class="bibtex secret"> <figure class="highlight"><pre><code class="language-bibtex" data-lang="bibtex"><span class="nc">@article</span><span class="p">{</span><span class="nl">Gros_2024</span><span class="p">,</span>
  <span class="na">abbr</span> <span class="p">=</span> <span class="s">{JCC}</span><span class="p">,</span>
  <span class="na">bibtex_show</span> <span class="p">=</span> <span class="s">{false}</span><span class="p">,</span>
  <span class="na">title</span> <span class="p">=</span> <span class="s">{Tofacitinib versus vedolizumab among bio-naïve patients with ulcerative colitis: A real-world propensity-weighted comparison}</span><span class="p">,</span>
  <span class="na">issn</span> <span class="p">=</span> <span class="s">{1876-4479}</span><span class="p">,</span>
  <span class="na">url</span> <span class="p">=</span> <span class="s">{http://dx.doi.org/10.1093/ecco-jcc/jjae188}</span><span class="p">,</span>
  <span class="na">doi</span> <span class="p">=</span> <span class="s">{10.1093/ecco-jcc/jjae188}</span><span class="p">,</span>
  <span class="na">journal</span> <span class="p">=</span> <span class="s">{Journal of Crohn's and Colitis}</span><span class="p">,</span>
  <span class="na">publisher</span> <span class="p">=</span> <span class="s">{Oxford University Press (OUP)}</span><span class="p">,</span>
  <span class="na">author</span> <span class="p">=</span> <span class="s">{Constantine-Cooke, Nathan and Gros, Beatriz and Kennedy, Jake and Elford, Alexander T and O'Hare, Claire and Noble, Colin and Jones, Gareth-Rhys and Arnott, Ian D and Lees, Charlie W and Plevris, Nikolas}</span><span class="p">,</span>
  <span class="na">year</span> <span class="p">=</span> <span class="s">{2024}</span><span class="p">,</span>
  <span class="na">month</span> <span class="p">=</span> <span class="nv">dec</span><span class="p">,</span>
  <span class="na">selected</span> <span class="p">=</span> <span class="s">{true}</span>
<span class="p">}</span></code></pre></figure> </div> </div> </div> </li> <li> <div class="row"> <div class="col-sm-2 abbr"><abbr class="badge">TAG</abbr></div> <div id="doi:10.1177/17562848211064004" class="col-sm-8"> <div class="title">Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis</div> <div class="author">Laura A. Lucaciu,  <em>Nathan Constantine-Cooke</em>, Nikolas Plevris, Spyros Siakavellas, Lauranne A.A.P. Derikx, Gareth-Rhys Jones, and <a href="https://charlielees.com" rel="external nofollow noopener" target="_blank">Charles W. Lees</a> </div> <div class="periodical"> <em>Therapeutic Advances in Gastroenterology</em> Dec 2021 </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a class="bibtex btn btn-sm z-depth-0" role="button">Bib</a> <a href="https://doi.org/10.1177/17562848211064004" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">URL</a> <a href="/assets/pdf/tag2021.pdf" class="btn btn-sm z-depth-0" role="button">PDF</a> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script><div data-altmetric-id="119733825" class="altmetric-embed" data-hide-no-mentions="true" data-hide-less-than="0" data-badge-popover="right" data-badge-type="2" style="display:inline"></div> </div> <div class="abstract secret"> <p>Background and aims: Tofacitinib is a Janus kinase inhibitor (JAKi) recently approved for the treatment of moderate to severe ulcerative colitis (UC) based on robust efficacy and safety data derived from OCTAVE clinical trials. Evidence on the outcomes of tofacitinib therapy in real-world UC patients is needed, as a number of these patients would be deemed ineligible for clinical trials. We have therefore summarised data derived from observational, real-world evidence (RWE) studies on the effectiveness and safety of tofacitinib in moderate to severe UC patients. Methods: We searched the PubMed, EMBASE, Scopus, Web of Science and Cochrane databases for observational studies on the use of tofacitinib in UC patients, published between 30 May 2018 and 24 January 2021. Pooled induction (8-14 weeks) and maintenance (16-26 weeks) clinical response and remission rates were calculated, as well as the proportion of reported adverse events using random effects models. Results: Nine studies were included, comprising 830 patients, of which 81% were previously treated with anti-tumour necrosis factor (TNF) and 57% with vedolizumab. Induction of clinical response and remission were achieved in 51% (95% confidence interval, 41-60%) and 37% (26-45%) of patients, after a median follow-up of 8 weeks. At the end of a median follow-up of 24 weeks, maintenance of clinical response and remission were met in 40% (31-50%) and 29% (23-36%) of patients, respectively. Thirty-two percent of the patients had at least one adverse event, the most commonly reported being mild infection (13%) and worsening of UC, requiring colectomy (13%). A third of the patients (35%) discontinued tofacitinib, most frequently due to primary non-response (51%). Conclusion: Tofacitinib is a safe and effective therapy in real-world UC patients, as previously reported by clinical trials.</p> </div> <div class="bibtex secret"> <figure class="highlight"><pre><code class="language-bibtex" data-lang="bibtex"><span class="nc">@article</span><span class="p">{</span><span class="nl">doi:10.1177/17562848211064004</span><span class="p">,</span>
  <span class="na">abbr</span> <span class="p">=</span> <span class="s">{TAG}</span><span class="p">,</span>
  <span class="na">bibtex_show</span> <span class="p">=</span> <span class="s">{true}</span><span class="p">,</span>
  <span class="na">selected</span> <span class="p">=</span> <span class="s">{true}</span><span class="p">,</span>
  <span class="na">pdf</span> <span class="p">=</span> <span class="nv">tag2021.pdf</span><span class="p">,</span>
  <span class="na">author</span> <span class="p">=</span> <span class="s">{Lucaciu, Laura A. and Constantine-Cooke, Nathan and Plevris, Nikolas and Siakavellas, Spyros and Derikx, Lauranne A.A.P. and Jones, Gareth-Rhys and Lees, Charles W.}</span><span class="p">,</span>
  <span class="na">title</span> <span class="p">=</span> <span class="s">{Real-world experience with tofacitinib in ulcerative colitis: a systematic review and meta-analysis}</span><span class="p">,</span>
  <span class="na">journal</span> <span class="p">=</span> <span class="s">{Therapeutic Advances in Gastroenterology}</span><span class="p">,</span>
  <span class="na">volume</span> <span class="p">=</span> <span class="s">{14}</span><span class="p">,</span>
  <span class="na">number</span> <span class="p">=</span> <span class="s">{}</span><span class="p">,</span>
  <span class="na">pages</span> <span class="p">=</span> <span class="s">{17562848211064004}</span><span class="p">,</span>
  <span class="na">month</span> <span class="p">=</span> <span class="nv">dec</span><span class="p">,</span>
  <span class="na">year</span> <span class="p">=</span> <span class="s">{2021}</span><span class="p">,</span>
  <span class="na">doi</span> <span class="p">=</span> <span class="s">{10.1177/17562848211064004}</span><span class="p">,</span>
  <span class="na">note</span> <span class="p">=</span> <span class="s">{PMID: 34987608}</span><span class="p">,</span>
  <span class="na">altmetric</span> <span class="p">=</span> <span class="s">{119733825}</span><span class="p">,</span>
  <span class="na">url</span> <span class="p">=</span> <span class="s">{https://doi.org/10.1177/17562848211064004}</span><span class="p">,</span>
  <span class="na">eprint</span> <span class="p">=</span> <span class="s">{https://doi.org/10.1177/17562848211064004}</span>
<span class="p">}</span></code></pre></figure> </div> </div> </div> </li> <li> <div class="row"> <div class="col-sm-2 abbr"><abbr class="badge">CGH</abbr></div> <div id="Constantine_Cooke_2023" class="col-sm-8"> <div class="title">Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn’s Disease</div> <div class="author"> <em>Nathan Constantine-Cooke</em>, Karla Monterrubio-Gómez, Nikolas Plevris, Lauranne A.A.P. Derikx, Beatriz Gros, Gareth-Rhys Jones, Riccardo E. Marioni, <a href="https://charlielees.com" rel="external nofollow noopener" target="_blank">Charlie W. Lees</a>, and <a href="https://vallejosgroup.github.io" rel="external nofollow noopener" target="_blank">Catalina A. Vallejos</a> </div> <div class="periodical"> <em>Clinical Gastroenterology and Hepatology</em> Mar 2023 </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abs</a> <a class="bibtex btn btn-sm z-depth-0" role="button">Bib</a> <a href="https://www.sciencedirect.com/science/article/pii/S1542356523002343" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">URL</a> <a href="/assets/pdf/LCMM_CGH.pdf" class="btn btn-sm z-depth-0" role="button">PDF</a> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script><div data-altmetric-id="144689897" class="altmetric-embed" data-hide-no-mentions="true" data-hide-less-than="0" data-badge-popover="right" data-badge-type="2" style="display:inline"></div> </div> <div class="abstract secret"> <p>Background and Aims The progressive nature of Crohn’s disease is highly variable and hard to predict. In addition, symptoms correlate poorly with mucosal inflammation. There is therefore an urgent need to better characterize the heterogeneity of disease trajectories in Crohn’s disease by utilizing objective markers of inflammation. We aimed to better understand this heterogeneity by clustering Crohn’s disease patients with similar longitudinal fecal calprotectin profiles. Methods We performed a retrospective cohort study at the Edinburgh IBD Unit, a tertiary referral center, and used latent class mixed models to cluster Crohn’s disease subjects using fecal calprotectin observed within five years of diagnosis. Information criteria, alluvial plots, and cluster trajectories were used to decide the optimal number of clusters. Chi-squared, Fisher’s exact test, and ANOVA were used to test for associations with variables commonly assessed at diagnosis. Results Our study cohort comprised of 365 patients with newly diagnosed Crohn’s disease and 2856 fecal calprotectin measurements taken within five years of diagnosis (median 7 per subject). Four distinct clusters were identified by characteristic calprotectin profiles: a cluster with consistently high fecal calprotectin and three clusters characterized by different downward longitudinal trends. Cluster membership was significantly associated with smoking (p = 0.015), upper gastrointestinal involvement (p &lt; 0.001), and early biologic therapy (p &lt; 0.001). Conclusions Our analysis demonstrates a novel approach to characterizing the heterogeneity of Crohn’s disease by using fecal calprotectin. The group profiles do not simply reflect different treatment regimens and do not mirror classical disease progression endpoints.</p> </div> <div class="bibtex secret"> <figure class="highlight"><pre><code class="language-bibtex" data-lang="bibtex"><span class="nc">@article</span><span class="p">{</span><span class="nl">Constantine_Cooke_2023</span><span class="p">,</span>
  <span class="na">abbr</span> <span class="p">=</span> <span class="s">{CGH}</span><span class="p">,</span>
  <span class="na">bibtex_show</span> <span class="p">=</span> <span class="s">{true}</span><span class="p">,</span>
  <span class="na">selected</span> <span class="p">=</span> <span class="s">{true}</span><span class="p">,</span>
  <span class="na">pdf</span> <span class="p">=</span> <span class="s">{LCMM_CGH.pdf}</span><span class="p">,</span>
  <span class="na">doi</span> <span class="p">=</span> <span class="s">{10.1016/j.cgh.2023.03.026}</span><span class="p">,</span>
  <span class="na">issn</span> <span class="p">=</span> <span class="s">{1542-3565}</span><span class="p">,</span>
  <span class="na">url</span> <span class="p">=</span> <span class="s">{https://www.sciencedirect.com/science/article/pii/S1542356523002343}</span><span class="p">,</span>
  <span class="na">year</span> <span class="p">=</span> <span class="s">{2023}</span><span class="p">,</span>
  <span class="na">month</span> <span class="p">=</span> <span class="nv">mar</span><span class="p">,</span>
  <span class="na">altmetric</span> <span class="p">=</span> <span class="s">{144689897}</span><span class="p">,</span>
  <span class="na">publisher</span> <span class="p">=</span> <span class="s">{Elsevier {BV}}</span><span class="p">,</span>
  <span class="na">author</span> <span class="p">=</span> <span class="s">{Constantine-Cooke, Nathan and Monterrubio-G{\'{o}}mez, Karla and Plevris, Nikolas and Derikx, Lauranne A.A.P. and Gros, Beatriz and Jones, Gareth-Rhys and Marioni, Riccardo E. and Lees, Charlie W. and Vallejos, Catalina A.}</span><span class="p">,</span>
  <span class="na">title</span> <span class="p">=</span> <span class="s">{Longitudinal Fecal Calprotectin Profiles Characterize Disease Course Heterogeneity in Crohn's Disease}</span><span class="p">,</span>
  <span class="na">journal</span> <span class="p">=</span> <span class="s">{Clinical Gastroenterology and Hepatology}</span><span class="p">,</span>
  <span class="na">keywords</span> <span class="p">=</span> <span class="s">{Biomarker, Epidemiology, Monitoring}</span>
<span class="p">}</span></code></pre></figure> </div> </div> </div> </li> </ol> </div> <br> <style type="text/css">#inner{display:table;margin:0 auto}#outer{width:100%}</style> <div id="outer"> <div id="inner"> <a class="twitter-timeline" data-width="500" data-tweet-limit="3" href="https://twitter.com/IBDNathan?ref_src=twsrc%5Etfw" rel="external nofollow noopener" target="_blank">Tweets by IBDNathan</a> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script> </div> </div> <br> <div class="social"> <div class="contact-icons"> <a href="mailto:%6E%61%74%68%61%6E.%63%6F%6E%73%74%61%6E%74%69%6E%65-%63%6F%6F%6B%65@%65%64.%61%63.%75%6B" title="email"><i class="fas fa-envelope"></i></a> <a href="https://orcid.org/0000-0002-4437-8713" title="ORCID" rel="external nofollow noopener" target="_blank"><i class="ai ai-orcid"></i></a> <a href="https://scholar.google.com/citations?user=2emHWR0AAAAJ" title="Google Scholar" rel="external nofollow noopener" target="_blank"><i class="ai ai-google-scholar"></i></a> <a href="https://www.researchgate.net/profile/Nathan-Constantine-Cooke/" title="ResearchGate" rel="external nofollow noopener" target="_blank"><i class="ai ai-researchgate"></i></a> <a href="https://github.com/nathansam" title="GitHub" rel="external nofollow noopener" target="_blank"><i class="fab fa-github"></i></a> <a href="https://www.linkedin.com/in/nathan-constantine-cooke" title="LinkedIn" rel="external nofollow noopener" target="_blank"><i class="fab fa-linkedin"></i></a> <a href="https://twitter.com/IBDNathan" title="Twitter" rel="external nofollow noopener" target="_blank"><i class="fab fa-twitter"></i></a> <a rel="me" href="https://fosstodon.org/@IBDNathan" title="Mastodon" target="_blank"><i class="fab fa-mastodon"></i> </a><a href="https://www.ed.ac.uk/profile/constantine-cooke" title="Work" rel="external nofollow noopener" target="_blank"><i class="fas fa-briefcase"></i></a> </div> <div class="contact-note"> </div> </div> </article> </div> </div> <footer class="fixed-bottom"> <div class="container mt-0"> © Copyright 2025 Nathan Constantine-Cooke. </div> </footer> <script defer src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.1/dist/js/bootstrap.bundle.min.js" integrity="sha256-fgLAgv7fyCGopR/gBNq2iW3ZKIdqIcyshnUULC4vex8=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@4/imagesloaded.pkgd.min.js"></script> <script defer src="/assets/js/masonry.js" type="text/javascript"></script> <script async src="https://cdn.jsdelivr.net/npm/medium-zoom@1.0.6/dist/medium-zoom.min.js" integrity="sha256-EdPgYcPk/IIrw7FYeuJQexva49pVRZNmt3LculEr7zM=" crossorigin="anonymous"></script> <script async src="/assets/js/zoom.js"></script> <script async src="/assets/js/common.js"></script> <script async type="text/javascript">window.MathJax={tex:{tags:"ams"}};</script> <script async type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.0/es5/tex-mml-chtml.js"></script> <script async src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script> <script async src="https://www.googletagmanager.com/gtag/js?id=UA-221003730-1"></script> <script>function gtag(){window.dataLayer.push(arguments)}window.dataLayer=window.dataLayer||[],gtag("js",new Date),gtag("config","UA-221003730-1");</script> <script type="text/javascript">function progressBarSetup(){"max"in document.createElement("progress")?(initializeProgressElement(),$(document).on("scroll",function(){progressBar.attr({value:getCurrentScrollPosition()})}),$(window).on("resize",initializeProgressElement)):(resizeProgressBar(),$(document).on("scroll",resizeProgressBar),$(window).on("resize",resizeProgressBar))}function getCurrentScrollPosition(){return $(window).scrollTop()}function initializeProgressElement(){let e=$("#navbar").outerHeight(!0);$("body").css({"padding-top":e}),$("progress-container").css({"padding-top":e}),progressBar.css({top:e}),progressBar.attr({max:getDistanceToScroll(),value:getCurrentScrollPosition()})}function getDistanceToScroll(){return $(document).height()-$(window).height()}function resizeProgressBar(){progressBar.css({width:getWidthPercentage()+"%"})}function getWidthPercentage(){return getCurrentScrollPosition()/getDistanceToScroll()*100}const progressBar=$("#progress");window.onload=function(){setTimeout(progressBarSetup,50)};</script> </div> </body> </html>